Replies to post #5024 on Halozyme Therapeutics Inc (HALO)

[maumar]

Well, XBI closed down slightly and there is no guarantee that "great news" is about to be released.

We are supposed to get two good pieces of news before the end of the year - one of the Enhanze partners moving to phase 2/3 and a new Enhanze partner - but because of the sector malaise (XBI around $60 from the high of $90 in July '15, that type of good news may just not be enough to push the stock much higher.

Great news would be filing on the basis of the 202 study but I suspect we would need at least 12 or 13 months PFS. We are probably not there yet.

Volume was low today. There could be technical reasons too. Fibonacci retracement? More support at 11?

Anybody else want to comment on the recent weakness?